CCNE1 and breast cancer: Equally significant, an over-expression of cyclin E has been shown to be associated with a poor prognosis in the patients with breast cancer [44], and down-regulation of cyclin E by siRNA suppressed tumor growth in a xenograft model of breast cancer [45].